Physician

Mark S Shimko, MD

According to 2025 Medicare claims, Mark Shimko, MD (NPI: 1457541278) practices urology in the Salisbury, MD market, with the plurality of this provider's patient population coming from Wicomico, MD. This provider's primary affiliated billing organization is CHESAPEAKE UROLOGY ASSOCIATES, LLC (NPI: 1194147835; TIN: 522146172) and primary practice location at 21804-5109.

Shimko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,144 traditional Medicare patients, billed 6,718 HCPCS/CPT codes, and received $319,605 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,254 prescription claims across 551 beneficiaries totaling $5,255,060 in drug costs, led by Xtandi (Enzalutamide). DME data shows 27 claims. Open Payments data shows 37 records totaling $969. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $425,765 and ending at $319,605. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $73,642 to $5,255,060. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,774	10,991	$425,765
2016	1,726	10,149	$430,522
2017	1,505	6,521	$362,779
2018	1,321	5,825	$319,226
2019	1,512	9,915	$907,312
2020	1,017	8,714	$356,511
2021	1,224	9,575	$357,428
2022	1,149	12,271	$466,895
2023	1,239	7,117	$549,049
2024	1,144	6,718	$319,605

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	335	924	$73,642
2016	392	1,090	$91,068
2017	416	1,111	$88,205
2018	448	1,331	$123,172
2019	416	1,290	$372,621
2020	363	1,268	$723,981
2021	383	1,292	$1,491,066
2022	438	1,505	$2,428,667
2023	515	1,852	$3,402,320
2024	551	2,254	$5,255,060

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	38	$11,212
2016	11	35	$12,178
2017	14	61	$15,859
2018	15	60	$18,904
2019	14	90	$35,386
2020	17	114	$47,122
2021	14	84	$28,056
2022	14	71	$25,577
2023	13	50	$19,046
2024	N/R	27	$16,649

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	565	753	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	228	241	$56
52000	Diagnostic exam of bladder and urethra using an endoscope	196	247	$55
76775	Limited ultrasound scan behind abdominal cavity	224	246	$42
51798	Ultrasound measurement of bladder capacity after voiding	118	137	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	175	5,310	$2,430,630
Erleada	Apalutamide	87	2,730	$1,299,552
Nubeqa	Darolutamide	52	1,560	$700,356
Orgovyx	Relugolix	227	7,050	$614,353
Abiraterone Acetate	Abiraterone Acetate	48	1,440	$69,111

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	27	$16,649

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$969	Teleflex LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark S. Shimko, MD?

Tedicare shows public-source Medicare data for Mark S. Shimko, MD (NPI 1457541278), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark S. Shimko, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark S. Shimko, MD?

Mark S. Shimko, MD is linked to CHESAPEAKE UROLOGY ASSOCIATES, LLC (billing NPI 1194147835) in the available physician profile data.

Does Mark S. Shimko, MD have Open Payments data?

Mark S. Shimko, MD has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.